Phase 1b/3 Pharmacokinetics and Safety Study of Intravenous Posaconazole in Adult Asian Participants at High Risk for Invasive Fungal Infections

被引：0

作者：

Depei Wu

Yingchang Mi

Jianyu Weng

Junling Zhuang

Xiaoyan Ke

Chun Wang

Kaiyan Liu

Monika Martinho

Gregory A. Winchell

Yanqiao Zang

Lianzhe Xu

机构：

[1] The First Affiliated Hospital of Soochow University,Hematology Department

[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Institute of Hematology and Blood Diseases Hospital

[3] Guangdong Provincial People’s Hospital,undefined

[4] Guangdong Academy of Medical Science,undefined

[5] Peking Union Medical College Hospital,undefined

[6] Peking University Third Hospital,undefined

[7] Shanghai General Hospital,undefined

[8] Peking University People’s Hospital,undefined

[9] Merck & Co.,undefined

[10] Inc,undefined

[11] Certara USA,undefined

[12] Inc,undefined

来源：

Advances in Therapy | 2022年 / 39卷

关键词：

Posaconazole; Pharmacokinetics; Triazole antifungal;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1697 / 1710

页数：13

共 22 条

[21] Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study [J].

Olayemi Osiyemi ;

Salih Yasin ;

Carmen Zorrilla ;

Ceyhun Bicer ;

Vera Hillewaert ;

Kimberley Brown ;

Herta M. Crauwels .

Infectious Diseases and Therapy, 2018, 7 :147-159

[22] Safety, Pharmacokinetics, and Pharmacodynamics of Trazpiroben (TAK-906), a Novel Selective D2/D3 Receptor Antagonist: A Phase 1 Randomized, Placebo-Controlled Single- and Multiple-Dose Escalation Study in Healthy Participants [J].

Whiting, Roger L. ;

Darpo, Borje ;

Chen, Chunlin ;

Fletcher, Margaret ;

Combs, Dan ;

Xue, Hongqi ;

Stoltz, Randall R. .

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (08) :927-939

← 1 2 3 →